Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation
ClinicalTrials.gov study NCT01581515. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC
ClinicalTrials.gov study NCT03912389. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed
ClinicalTrials.gov study NCT04524689. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
ClinicalTrials.gov study NCT05668988. IPD Sharing: NO. Countries: 16. Publications: 1.
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06877299. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum
ClinicalTrials.gov study NCT01426126. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma
ClinicalTrials.gov study NCT04678362. IPD Sharing: NO. Countries: 1. Publications: 1.
Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy
ClinicalTrials.gov study NCT03364907. IPD Sharing: NO. Countries: 1. Publications: 1.
An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT00532194. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01837251. IPD Sharing: Not stated. Countries: 6. Publications: 1.
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov study NCT00052065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
ClinicalTrials.gov study NCT04814875. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02545010. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02679963. IPD Sharing: NO. Countries: 1. Publications: 1.
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT03117933. IPD Sharing: NO. Countries: 1. Publications: 2.
Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04720807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
ClinicalTrials.gov study NCT03188159. IPD Sharing: NO. Countries: 2. Publications: 4.
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
ClinicalTrials.gov study NCT05316181. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02659384. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03587129. IPD Sharing: NO. Countries: 1. Publications: 15.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.